These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1358127)

  • 1. General pharmacology of clozapine.
    Coward DM
    Br J Psychiatry Suppl; 1992 May; (17):5-11. PubMed ID: 1358127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A neurochemical basis for the antipsychotic activity of loxapine: interactions with dopamine D1, D2, D4 and serotonin 5-HT2 receptor subtypes.
    Singh AN; Barlas C; Singh S; Franks P; Mishra RK
    J Psychiatry Neurosci; 1996 Jan; 21(1):29-35. PubMed ID: 8580115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S18327 (1-[2-[4-(6-fluoro-1, 2-benzisoxazol-3-yl)piperid-1-yl]ethyl]3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1)- and alpha(2)-adrenergic receptors: II. Functional profile and a multiparametric comparison with haloperidol, clozapine, and 11 other antipsychotic agents.
    Millan MJ; Brocco M; Rivet JM; Audinot V; Newman-Tancredi A; Maiofiss L; Queriaux S; Despaux N; Peglion JL; Dekeyne A
    J Pharmacol Exp Ther; 2000 Jan; 292(1):54-66. PubMed ID: 10604931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of alpha2-adrenoceptor antagonism in the anti-cataleptic properties of the atypical neuroleptic agent, clozapine, in the rat.
    Kalkman HO; Neumann V; Hoyer D; Tricklebank MD
    Br J Pharmacol; 1998 Aug; 124(7):1550-6. PubMed ID: 9723970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity.
    Leysen JE; Janssen PM; Megens AA; Schotte A
    J Clin Psychiatry; 1994 May; 55 Suppl():5-12. PubMed ID: 7520908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology of fluperlapine compared with clozapine.
    Eichenberger E
    Arzneimittelforschung; 1984; 34(1A):110-3. PubMed ID: 6145425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological studies with two new ergoline derivatives, the potential antipsychotics LEK-8829 and LEK-8841.
    Krisch I; Bole-Vunduk B; Pepelnak M; Lavric B; Ocvirk A; Budihna MV; Sket D
    J Pharmacol Exp Ther; 1994 Oct; 271(1):343-52. PubMed ID: 7965734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dopamine D4-receptor variants, schizophrenia and clozapine therapy].
    Ewald HL; Mors NP; Rosenberg R
    Ugeskr Laeger; 1996 Jun; 158(25):3601-3. PubMed ID: 8693618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QF2004B, a potential antipsychotic butyrophenone derivative with similar pharmacological properties to clozapine.
    Brea J; Castro M; Loza MI; Masaguer CF; Raviña E; Dezi C; Pastor M; Sanz F; Cabrero-Castel A; Galán-Rodríguez B; Fernández-Espejo E; Maldonado R; Robledo P
    Neuropharmacology; 2006 Aug; 51(2):251-62. PubMed ID: 16697427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic treatment with clozapine or haloperidol differentially regulates dopamine and serotonin receptors in rat brain.
    O'Dell SJ; La Hoste GJ; Widmark CB; Shapiro RM; Potkin SG; Marshall JF
    Synapse; 1990; 6(2):146-53. PubMed ID: 2237777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The atypical antipsychotic profile of NRA0045, a novel dopamine D4 and 5-hydroxytryptamine2A receptor antagonist, in rats.
    Okuyama S; Chaki S; Kawashima N; Suzuki Y; Ogawa S; Kumagai T; Nakazato A; Nagamine M; Yamaguchi K; Tomisawa K
    Br J Pharmacol; 1997 Jun; 121(3):515-25. PubMed ID: 9179395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PNU-96415E, a potential antipsychotic agent with clozapine-like pharmacological properties.
    Tang AH; Franklin SR; Himes CS; Smith MW; Tenbrink RE
    J Pharmacol Exp Ther; 1997 Apr; 281(1):440-7. PubMed ID: 9103528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-745,870, a subtype selective dopamine D4 receptor antagonist, does not exhibit a neuroleptic-like profile in rodent behavioral tests.
    Bristow LJ; Collinson N; Cook GP; Curtis N; Freedman SB; Kulagowski JJ; Leeson PD; Patel S; Ragan CI; Ridgill M; Saywell KL; Tricklebank MD
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1256-63. PubMed ID: 9400001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clozapine and resistant schizophrenia].
    Pere JJ; Chaumet-Riffaud D
    Encephale; 1990; 16(2):143-5. PubMed ID: 1972053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopaminergic and serotonergic effects of clozapine. Implications for a unique clinical profile.
    Meltzer HY; Gudelsky GA
    Arzneimittelforschung; 1992 Feb; 42(2A):268-72. PubMed ID: 1586397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of dopamine D2 receptors in the CNS inhibits sympathetic cutaneous vasomotor alerting responses (SCVARs), contributing to clozapine's SCVAR-inhibiting action.
    Blessing WW; Ootsuka Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):328-36. PubMed ID: 17055139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypothesis testing: is clozapine's superior efficacy dependent on moderate D2 receptor occupancy?
    Carpenter WT; Zito JM; Vitrai J; Volavka J
    Biol Psychiatry; 1998 Jan; 43(2):79-83. PubMed ID: 9474440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine receptor pharmacology.
    Seeman P; Van Tol HH
    Curr Opin Neurol Neurosurg; 1993 Aug; 6(4):602-8. PubMed ID: 8104554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychopharmacological profile of remoxipride in comparison with clozapine.
    Skuza G; Rogóz Z; Wieczorek A
    Pol J Pharmacol; 1997; 49(1):5-15. PubMed ID: 9431546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic clozapine treatment decreases 5-hydroxytryptamine1C receptor density in the rat choroid plexus: comparison with haloperidol.
    Kuoppamäki M; Seppälä T; Syvälahti E; Hietala J
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1262-7. PubMed ID: 8383744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.